Key points are not available for this paper at this time.
The author reflects on the potential impacts that the American government's repeal of a Cuban embargo might have on U.S. medicine and public health as of 2015, and it mentions the medical research that various Cuban researchers have been carrying out regarding vaccines and preventive medicines. It states that Cuba's Finlay Institute has developed inexpensive hepatitis B virus vaccines. The U.S. Food and Drug Administration and Cuban-American diplomatic relations are assessed.
Paul K. Drain (2015) studied this question.